Shingles virus in the gut linked to swallowing disorder – new trial aims to treat it
NCT ID NCT05550194
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving anti-viral medication to kill the shingles virus (VZV) living in the gut can improve symptoms of achalasia, a severe swallowing disorder. Researchers will enroll 40 adults with achalasia and measure changes in swallowing, pain, and weight. The goal is to see if the virus causes the disease and if treatment can help.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHALASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37129, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nerve system glitches may worsen blood pressure swings during achalasia surgery — a study investigates
- New registry tracks POEM procedure for swallowing disorder
- New study investigates why some patients get worse reflux after esophagus surgery
- Small study seeks clues to weight loss mystery in achalasia
- Could adding a balloon stretch to botox help achalasia patients swallow better?
- Water vs. gas: can a simple change make a key esophagus surgery safer?